News of the Sifu movie was revealed years ago, but with Netflix now involved, it shouldn't be too long before we get a ...

The 2005 film adaptation of 'Constantine' is a glorious take on horror noir. Adrian Manuel explains on Dread Central.

Brave New World's theatrical cut omitted some MCU characters we saw in set photos, and I'm so sad one in particular didn't ...

It took a village of storytellers to bring “Kingdom of the Planet of the Apes” to life. At the heart of it all was VFX house Wētā, which had a crew of over 1000 artists working on delivering 1500 ...

Kristen Wiig and Bill Murray will star in the comedy Epiphany, which Rocket Science will introduce to international buyers at ...

The new virtual instrument is called, Cinematic Lights, and here’s what PreSonus had to say about it. Cinematic Lights combines heavily processed orchestral strings and bass elements with synth ...

Timothée Chalamet has said that he put on 20 pounds in order to play Bob Dylan in A Complete Unknown. In a recent interview with NPR, Chalamet described the lengths he went for the role: “I ...

Rochester Institute of Technology (RIT) transgender runner Sadie Schreiner boasted about a victory at a women’s track and field meet over the weekend. Schreiner won the 200-meter event with a ...

Luckily, his perfectionism and sheer dedication didn’t always manifest in such harmful ways. Within the film, there is a maze that plays a vital role. It is here that Jack chases after his own son, ...

Maze Therapeutics has set out plans for a $131 million IPO as the company prepares to start dosing its lead kidney drug in a phase 2 trial. The Bay Area-based biotech unveiled its ambition earlier ...

The result was absolutely captivating, a cinematic journey through an entire lifetime, its runtime entirely justified. It’s just, I could barely walk by the time the credits rolled. I literally ...

Maze seeks as much as $133 mln in New York IPO Backers include Alphabet's GV and Third Rock Ventures Biotech IPOs set for ramp up in coming weeks Jan 27 (Reuters) - Drug developer Maze ...